DAVITA INC. Proceeds from (Repayments of) Restricted Cash, Financing Activities
DAVITA INC. (DVA) reported Proceeds from (Repayments of) Restricted Cash, Financing Activities of -$1.27 billion for the 9-month period ending 2012-09-30, per its 10-Q filed 2013-11-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities · last filed 2013-11-06
- 2012-09-30: Proceeds from (Repayments of) Restricted Cash, Financing Activities 9 month -$1.27B.
| Period end | Proceeds from (Repayments of) Restricted Cash, Financing Activities 9 month |
|---|---|
| 2012-09-30 | -$1.27B 10-Q · filed 2013-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |